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https://doi.org/10.1016/j.celrep.2020.107586SUMMARYCodon pair deoptimization is an efficient virus attenuation strategy, but the mechanism that leads to atten-
uation is unknown. The strategy involves synthetic recoding of viral genomes that alters the positions of syn-
onymous codons, thereby increasing the number of suboptimal codon pairs and CpG dinucleotides in re-
coded genomes. Here we identify the molecular mechanism of codon pair deoptimization-based
attenuation by studying recoded influenza A viruses. We show that suboptimal codon pairs cause attenua-
tion, whereas the increase of CpG dinucleotides has no effect. Furthermore, we show that suboptimal codon
pairs reduce both mRNA stability and translation efficiency of codon pair-deoptimized genes. Consequently,
reduced protein production directly causes virus attenuation. Our study provides evidence that suboptimal
codon pairs are major determinants of mRNA stability. Additionally, it demonstrates that codon pair bias
can be used to increase mRNA stability and protein production of synthetic genes in many areas of
biotechnology.INTRODUCTION
Recent advances in the de novo synthesis of DNA enable large-
scale recoding of viral genomes (Coleman et al., 2008; Mueller
et al., 2010). Viruses with recoded genomes can be used as
modified live attenuated vaccines. The goal of the recoding is
to modify dinucleotide, codon, or codon pair composition of
the recoded viral genes, because all three types of potentially
interrelatedmodifications might produce replication-competent,
but attenuated viruses. Importantly, while recoding introduces
hundreds of point mutations into viral genomes, the amino acid
composition of the encoded proteins remains preserved. Conse-
quently, the recoded viruses are antigenically identical to their
pathogenic parents (Broadbent et al., 2016; Coleman et al.,
2008; Mueller et al., 2010). The antigenic identity and replicative
potential enable attenuated viruses to induce immune responses
that are similar to those of virulent strains.
Most of the amino acids are encoded by several codons. Or-
ganisms use synonymous codons with varying frequencies—a
phenomenon known as codon bias. In addition to codon bias,
protein coding sequences also show codon pair bias, which is
bias of two adjacent codons (Gutman and Hatfield, 1989; Kunec
and Osterrieder, 2016). Some codon pairs are found in protein
coding genes significantly more or less frequently than wouldThis is an open access article under the CC BY-Nbe expected based on the overall frequencies of two codons
that form a particular codon pair (Coleman et al., 2008; Gutman
and Hatfield, 1989; Mueller et al., 2006).
Codon pair deoptimization (CPD) is a highly efficient virus
attenuation strategy that utilizes suboptimal codon pairs to
achieve attenuation of recoded viruses. CPD rearranges the po-
sitions of existing synonymous codons in a viral gene, without
changing the codon bias or amino acid composition of the en-
coded protein (Coleman et al., 2008; Mueller et al., 2010). The
goal of the codon swapping is to increase the frequency of
codon pairs that are statistically underrepresented (suboptimal)
in the host genes. CPD has been widely used for the develop-
ment of viral vaccines, because it allows the generation of effica-
cious, non-reverting attenuated viruses with the desired degree
of attenuation (Coleman et al., 2008; Mueller et al., 2010). It is
broadly applicable for rapid and efficient attenuation of a wide
range of viruses including poliovirus (Coleman et al., 2008), influ-
enza A virus (IAV) (Broadbent et al., 2016; Mueller et al., 2010;
Yang et al., 2013), human immunodeficiency virus (Martrus
et al., 2013), and Dengue virus (Shen et al., 2015).
Despite its great potential, the molecular mechanisms that un-
derlie the attenuation by CPD have remained unknown (Broad-
bent et al., 2016; Coleman et al., 2008; Futcher et al., 2015; Le
Noue¨n et al., 2014; Shen et al., 2015; Simmonds et al., 2015;Cell Reports 31, 107586, April 28, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. In Silico Design and Properties of
Recoded IAV NA Genes
(A) Structure of the IAV NA segment and recoding
design. Only the central part of the NA gene was
recoded (light gray), because terminal non-coding
(black) and coding regions (gray) contain vRNA
packaging signals. Sequence length is in nucleo-
tides.
(B) Average codon pair score (CPS) and number of
CpG dinucleotides in recoded sequences of NA
genes. Red and green arrows represent CPD and
codon pair optimization, respectively.
(C) Distribution of CPS in recoded sequences of NA
genes. Each circle represents the CPS of a single
codon pair. Empty circles represent codon pairs that
do not contain CpG dinucleotides. Blue filled circles
represent codon pairs that contain CpG di-
nucleotides within the codons (CGN, or NCG). Red filled circles represent codon pairs of the NNC-GNN type. Note that all codon pairs of the NNC-GNN type have
negative CPS. Because each codon forms two different codon pairs, there are approximately twice as many codon pairs (24) as there are codons with a CpG
dinucleotide (12) in the recoded NA sequence. The gray density plots show the shape of the CPS distribution. The black lines indicate average CPS of the recoded
NA gene sequence.
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OPEN ACCESSYang et al., 2013). While different mechanisms have been pro-
posed, the prevailing hypothesis is that the large number of un-
derrepresented codon pairs interferes with efficient protein pro-
duction or processing (Coleman et al., 2008; Shen et al., 2015). It
is speculated that physical properties of specific tRNAs, such as
their 3D-structures, hamper their efficient fit into adjacent amino-
acyl- and peptidyl-sites in the translating ribosome (Coleman
et al., 2008). Consequently, codon pair-deoptimized sequences
may be prone to mistranslation, stalled translation, or premature
termination (Broadbent et al., 2016). It was discovered, however,
that CPD of vertebrate viruses not only affects codon pair bias,
but also dramatically increases the number of CpG and, to a
lesser degree, TpA (UpA) dinucleotides in recoded sequences
(Kunec and Osterrieder, 2016; Tulloch et al., 2014). The increase
of CpG dinucleotides through recoding is inadvertent and almost
inevitable, as codon pairs that contain CpG dinucleotides at the
codon pair boundary (NNC-p-GNN) are among the most under-
represented in vertebrates (Atkinson et al., 2014; Kunec and Os-
terrieder, 2016). Interestingly, most vertebrate RNA and small
DNA viruses also show suppression of CpG dinucleotides in their
genomes. Thus, an alternate hypothesis proposes that CpG di-
nucleotides are the sole cause of attenuation because they act
as triggers of antiviral immune responses (Greenbaum et al.,
2009). Recent studies showed that the host zinc-finger antiviral
protein (ZAP) is a long-suspected single-stranded RNA (ssRNA)
CpG receptor because it binds specifically to CpG-rich RNAs
and targets them for degradation by the RNA exosome (Ficarelli
et al., 2019; Takata et al., 2017). In addition, it was shown that
CPD can reduce stability of recoded mRNA (Broadbent et al.,
2016; Yang et al., 2013) and induce temperature-sensitivity in
mutant viruses (Le Noue¨n et al., 2014; Yang et al., 2013).
As codon pair preferences and dinucleotide frequencies are
tightly linked, disentangling the effects of two phenomena is
exquisitely difficult (Kunec and Osterrieder, 2016; Tulloch et al.,
2014). We here dissected the contribution of underrepresented
codon pairs from that of CpG dinucleotides on attenuation of re-
coded viruses. To separate the effect of the two features, we de-
signed and characterized a series of IAV mutants in which the2 Cell Reports 31, 107586, April 28, 2020two parameters were altered independently. We show that un-
derrepresented codon pairs were solely responsible for attenua-
tion of recoded viruses, whereas CpG dinucleotide frequencies
had a negligible effect. We show that decreased mRNA stability
and reduced translation efficiency underlie the attenuation by
CPD. Our work refutes the hypothesis that the effect of attenua-
tion can be explained solely by the increased number of CpG di-
nucleotides in recoded sequences. In addition, several recent
studies provided evidence that codon optimality is amajor deter-
minant of mRNA stability. Here we demonstrate that the identity
of codon pairs is another critical determinant of mRNA stability,
which profoundly affects protein output and, ultimately, fitness of
recoded viruses.
RESULTS
Design of Recoded Viruses
To separate the effects of CpG dinucleotides from the codon pair
bias on viral attenuation, we designed a series of IAV mutants
carrying recoded variants of the neuraminidase (NA) gene. As
an experimental model we used the mouse-adapted IAV strain
A/WSN/1933 (H1N1), which causes acute respiratory disease
in immunocompetent mice (Stuart-Harris, 1939). NA is a virion
envelope glycoprotein that facilitates the release of virus parti-
cles from the surface of infected host cells and their spread in
the respiratory tract. We chose the NA gene because it is
amenable to recoding and does not have alternative reading
frames (Mueller et al., 2010; Yang et al., 2013). All genomic
RNA segments of IAV contain cis-acting signals at their termini,
which are essential for the packaging of viral RNA (vRNA) seg-
ments into virions (Eisfeld et al., 2015). To ensure efficient pack-
aging of recodedNA segments, we have altered only 339 codons
(1,017 nt) from the central part of the gene and left the first 61
(183 nt) and the last 54 codons (162 nt) of the NA opening reading
frame (ORF) unchanged (Figure 1A).
The degeneracy of the genetic code allows encoding a protein
by a myriad of synonymous RNA or DNA sequences. The tar-
geted part of the NA gene could be encoded by 10218 different
Table 1. Properties of Recoded IAV H1N1 Strain A/WSN/1933 NA Genes
Name Description CpG UpA CPS CAI Codon Identity (%) Nucleotide Identity (%)
27-WT original CPS 27 54 0.00 0.74 100.0 100.0
72-Min minimal CPS 72 100 0.45 0.74 37.8 75.6
46-Med reduced CPS 46 77 0.23 0.74 61.4 83.6
72H-Max same number of NNC-GNN as 72-Min,
maximal CPS
72 57 0.05 0.74 39.2 76.3
72L-Max same NNC-GNN as 72-Min, maximal CPS 72 71 0.21 0.74 38.9 76.4
27-Min same NNC-GNN as 27-WT, minimal CPS 27 82 0.22 0.74 52.5 80.2
CpG, number of CpG dinucleotides in recoded sequences; UpA, number of UpA dinucleotides in recoded sequences; CPS, average codon pair score;
CAI, codon adaptation index (a measure of codon bias); Codon identity, percentage of codons that occupy the same position in the parental and re-
coded genes; Nucleotide identity, percentage of nucleotides that occupy the same position in the parental and recoded genes.
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OPEN ACCESSsequences. We designed five different NA variants by reshuffling
the naturally used codons. Therefore, all variants had the same
codon bias as the parental sequence. In contrast, the number
of CpG dinucleotides at the codon boundaries and the nature
of codon pairs varied considerably among the recoded variants
(Table 1). Codon pair bias can be quantified using the codon pair
score (CPS) statistics (Coleman et al., 2008), where statistically
underrepresented codon pairs have negative and overrepre-
sented codon pairs have positive CPS values. The average
CPS of a gene is calculated as the arithmetic mean of individual
CPS values, which is shown alongside CpG dinucleotide fre-
quencies in Figure 1B. The first part of our naming scheme indi-
cates the number of CpG nucleotides that are present in the re-
coded part of the NA gene. The second part indicates whether
the recoding lead to an increased (Max) or decreased (Med or
Min) average CPS of the recoded sequence, given the con-
straints (Figure 1B).
The NA gene variants were produced by three different recod-
ing strategies. The first set was produced by ‘‘regular’’ CPD (46-
Med and 72-Min) of the parental NA sequence (27-WT), without
exerting any constraint on the number of CpG dinucleotides in
recoded sequences. Because CPD inadvertently increases the
number of CpG dinucleotides, both 46-Med and 72-Min have
more CpG dinucleotides than 27-WT. The 72-Min variant has
the lowest attainable CPS, while 46-Med is moderately (‘‘me-
dium’’) codon pair deoptimized (Table 1). The number of CpG di-
nucleotides correlates linearly with the CPS (Figure 1B).
In the second recoding strategy, an NA gene variant was de-
signed to contain the same number of CpG dinucleotides as
27-WT but a lower CPS. The 27-Min was derived from the 27-
WT by CPD, but codon pairs of the NNC-GNN type were omitted
from the recoding. The remaining synonymous codons of the 27-
WT sequence were reshuffled to create as many underrepre-
sented codon pairs as possible, but generation of additional
codon pairs of the NNC-GNN type was disallowed (Figures 1B
and 1C; Table 1). As a consequence, 27-WT and 27-Min have
the same number of CpG dinucleotides (27), but 27-Min has
the minimal attainable CPS (Table 1). Note that it is impossible
to attain a lower CPS than that of the 27-Min (0.22) without
increasing the number of CpG dinucleotides in the recoded
sequence.
In the third set, the 72L-Max and 72H-Max mutants were de-
signed to contain 72 CpG dinucleotides, exactly as many asthe 72-Min, which has the lowest attainable CPS and a large
number of CpG dinucleotides, whereas the average CPS of
72L-Max and 72H-Max (L stands for low, H stands for high) is
increased (Figure 1B). The 72L-Max was designed to have the
exact same codon pairs of the NNC-GNN type as 72-Min (60
NNC-GNN codon pairs were omitted from the recoding) (Fig-
ure 1C). In contrast, codon pairs of the NNC-GNN type in the
72H-Max gene were designed to have the highest possible
CPS (Figure 1C). As a result, both gene variants contain
completely different codon pairs of the NNC-GNN type. NNC-
GNN codon pairs have the lowest possible CPS values in the
72L-Min, and the highest possible CPS values in the 72H-Max
variant. The remaining codon pairs in 72L-Max and 72H-Max
were chosen to have the highest possible CPS values.
Codon pair preferences and dinucleotide frequencies are inti-
mately related because the most underrepresented codon pairs
contain CpG dinucleotides at the codon pair boundary. Hence,
uncoupling the effects of the two phenomena is difficult (Broad-
bent et al., 2016; Futcher et al., 2015; Simmonds et al., 2015).
Previous studies attempted to separate the effects of the two
sequence features on attenuation of viruses. The separation re-
mained incomplete, however, because the analyzed viruses not
only differed in codon pair bias and CpG dinucleotide fre-
quencies but also in codon bias (Futcher et al., 2015; Tulloch
et al., 2014). The unique design of our recoded NA gene variants
enabled us to compare biological properties of mutant viruses
that either had the same number of CpG dinucleotides, or nearly
identical CPS (Figure 1B), but all contained exactly the same co-
dons. This in turn allowed us to cleanly separate the effects of un-
derrepresented codons, codon pairs, and CpG dinucleotides on
gene expression, and replication fitness, of recoded viruses.
CPD Viruses, but Not CpG-High Viruses, Are Strongly
Attenuated in Tissue Culture
The recoded NA segments were produced synthetically and in-
fectious IAV mutants were recovered using a reverse genetics
system of A/WSN/1933 (H1N1) (Hoffmann et al., 2000). The repli-
cation kinetics of all mutant viruses were compared to parental
27-WT virus in multi-step growth analyses in Madin-Darby
canine kidney (MDCK) epithelial (Figure 2A) and human basal
alveolar epithelial A549 cells (Figure 2B). In MDCK cells, only
the codon pair-deoptimized viruses 46-Med and 72-Min repli-
cated less efficiently than the 27-WT virus, and their viral titersCell Reports 31, 107586, April 28, 2020 3
Figure 2. Biological Properties of Recoded Viruses in Tissue Culture
(A and B) Multiple-step growth kinetics of parental 27-WT and recoded viruses in (A) MDCK and (B) A549 cells. Data are shown the means of three biological
replicates. Error bars show SD.
(C and D) Representative images of plaques formed by 27-WT and recoded viruses on MDCK (C) and A549 cells (D).
(E) Relative plaque diameters of 27-WT and recoded viruses onMDCK and A549monolayers three days post infection. p values were calculated using an ANOVA
Bonferroni’s multiple comparison test (***p < 0.001).
(F) Western blot analysis of NA, NP, and NS1 protein production in MDCK cells infected with the parental and recoded viruses 5 h after infection. Beta-actin was
used as loading control. The images are representative of three independent biological experiments. Original, uncropped images fromwestern blots are shown in
Figure S5.
Article
ll
OPEN ACCESSwere typically 10 times lower than those of the 27-WT virus. In
A549 cells, the growth kinetics of the viruses 72L-Max and 72H-
Max were indistinguishable from those of the 27-WT virus. In
contrast, three codon pair-deoptimized viruses 27-Min, 46-
Med, and 72-Min replicated with severely reduced kinetics
when compared to the 27-WT virus, and we recorded an
1,000–10,000 times lower output of infectious virus particles
by the codon pair-deoptimized viruses (Figure 2B).4 Cell Reports 31, 107586, April 28, 2020The growth of the recoded viruses was also investigated by
analyzing plaque formation onMDCK and A549monolayers (Fig-
ures 2C–2E). Three codon pair-deoptimized viruses 27-Min, 46-
Med, and 72-Min formed plaques that were significantly smaller
than those of the parental 27-WT virus (Figures 2C–2E). The
diameter of the plaques was 3–5 times smaller than those of
the 27-WT virus on MDCK and A549 cells. On the other hand,
the viruses with a high number of CpG dinucleotides, 72L-Max
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OPEN ACCESSand 72H-Max, produced plaques that were indistinguishable
from those of the 27-WT virus (Figures 2C–2E). In general, sizes
of virus plaques onMDCK and A549 cells correlatedwell with the
ability of the viruses to replicate in A549 cells (Figure 2B).
We hypothesized that the replication of mutant viruses in
MDCK and A549 cells might be a function of NA expression.
Western blot analyses revealed that viruses that form smaller
plaques than the parental 27-WT virus also produced less NA
protein in MDCK cells at 5-h post infection, indicating that
reduced levels of NA are most likely responsible for attenuation
of viral growth in cultured cells (Figure 2F). The codon pair-deop-
timized viruses 27-Min, 46-Med, and 72-Min produced less NA
protein than the parental virus. NA levels were the lowest and
almost undetectable in cells infected with the 72-Min virus. In
contrast, NA production was unaffected in cells infected with
72L-Max and 72H-Max viruses. As expected, all viruses pro-
duced comparable amounts of nonstructural protein 1 (NS1)
and nucleoprotein (NP), as these genes had not been recoded
(Figure 2F).
CPD Viruses Are Significantly Attenuated In Vivo
The studied viruses can be classified into two groups based on
their characteristics in tissue culture: the attenuated (27-Min,
46-Med, and 72-Min) and the non-attenuated (27-WT, 72L-
Max, and 72H-Max). Next, we examined their pathogenicity in
a mouse model of infection. Seven groups of nine 6-week-old
BALB/c mice were intranasally inoculated with 5 3 104 plaque-
forming units (PFUs) of the respective viruses. Animal health
and body weight were continuously monitored for 18 days (Fig-
ure 3A; Figure S1). Three mice from each group were euthanized
at 2, 5, and 18 days post infection (dpi). As expected, the
parental 27-WT virus caused severe clinical disease in the in-
fected mice. Similarly, almost all mice infected with the mutant
72H-Max virus, and most mice infected with the mutant 72L-
Max virus, developed severe pneumonia within the first few
days after infection. In contrast, mice that were infected with
codon pair-deoptimized viruses and mice of the mock-infected
control group showed no apparent clinical signs of respiratory
disease (Figure 3A; Figure S1).
To obtain a more accurate picture of the virulence of the engi-
neered viruses, we determined the lung virus titers by plaque as-
says and qPCR, and examined pathological changes in the lungs
of infected animals. The parental 27-WT, 72L-Max, and 72H-
Max viruses replicated very efficiently and to comparable levels
in the lungs of infected mice. On the other hand, the number of
infectious viruses (Figure 3B) as well as NP (Figure 3C) and NA
RNA copy numbers (Figure S2A) were 10–1,000 times lower in
lungs of mice infected with the codon pair-deoptimized viruses
27-Min, 46-Med, and 72-Min when compared to the 27-WT con-
trol group. The 72-Min virus showed strongest attenuation and
no infectious virus could be detected in lungs of infected animals
at 5 dpi.
No infectious virus could be detected in any of the mice at 18
dpi. To evaluate the immune response to infection, we quantified
the level of antibodies to IAV present in sera by microneutraliza-
tion and hemagglutination inhibition (HAI) assays. Mice infected
with the codon pair-deoptimized viruses 27-Min, 46-Med, and
72-Min and the single surviving mouse infected with 72L-Maxshowed high antibody titers (Figures S2B and S2C), indicating
that these viruses induced robust immune responses.
We also quantified the degree of necrosis in bronchi, bron-
chioli, and alveoli (Figures S2D and S2E, 3D, and S3, respec-
tively), inflammatory infiltration of leukocytes into interstitial
and perivascular spaces (Figures 3E and 3F; Figure S3), and
occurrence of the bronchus-associated lymphoid tissue (BALT)
(Figures S2F and S3). Mice infected with the 27-WT, 72L-Max,
and 72H-Max viruses developed similar lung histopathologies.
Necrosis was most prominent in bronchioli but was also present
in the bronchi and alveoli. In contrast, mice infected with the 27-
Min and 46-Med viruses developed only mild pneumonia with
limited necrosis and inflammation. The 72-Min virus was virtually
apathogenic and lungs of mice infected with the 72-Min virus
resembled those of the control group, since no histopathological
signs of lung diseasewere present. Nevertheless, robust antiviral
T cell responses were induced in all infected groups, as evi-
denced by in the production of high IFN-g levels by spleen cells
in response to re-stimulation with the 27-WT virus 18 days after
infection (Figure 3G).
Histological examination of the diseased mice confirmed that
mice displayed moderate to severe, multifocal to coalescing,
and acute necrotizing bronchointerstitial pneumonia. Immuno-
histochemical staining of lung tissues confirmed that IAV was
the cause of pneumonia, because IAV antigen was widely
distributed in the lungs of severely diseased mice. Virus antigen
was detected in intact and necrotic bronchiolar and bronchial
epithelial cells, within alveolar macrophages, and in necrotic
cellular debris in airway lumina (Figure 3H).
CPD Virus Vaccine Candidates Protect Mice against
Challenge Infection
We next conducted a vaccination experiment to test whether vi-
ruses that showed no overt disease symptoms in the first exper-
iment (27-Min, 46-Med, and 72-Min) could induce protective im-
munity against lethal challenge with the parental 27-WT virus.
Eight 6-week-old mice were immunized by intranasal inoculation
with 5 3 104 PFUs of the recoded viruses and body weight was
monitored (Figure S4A). After 28 days, the mice were challenged
with 53 105 PFUs of 27-WT virus. All attenuated viruses induced
complete protection against the challenge with the 27-WT virus.
Immunized mice did not show any body weight loss upon chal-
lenge (Figure 4A), and virus was cleared 10 days after challenge
as no RNA copies could be detected. All three attenuated viruses
induced strong adaptive immune responses, detected as high
anti-IAV antibody titers (Figure 4B) and prominent virus-specific
interferon-gamma (IFN-g) responses in immunized mice (Fig-
ure S4B). There was no detectable necrosis (Figure 4C; Fig-
ure S4) and onlymild inflammation (Figures 4D and 4F; Figure S4)
in the lungs of protected animals.
In contrast, all mice of the control group lost considerable
weight. Lungs of the mock-vaccinated mice developed lesions
(Figures 4C–4F; Figure S4) and high viral titers were recorded
on days 3 and 4 after challenge (Figure S4F). Two out of six
mice recovered from severe weight loss (Figure 4A), possibly
due to age-dependent immunity, as the mice were at the day
of challenge 4weeks older than in the first experiment. Neverthe-
less, the lungs of these two mice were severely damaged andCell Reports 31, 107586, April 28, 2020 5
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Figure 3. Pulmonary Histopathology and Immune Responses in Infected Mice
(A) The relative body weight of the mice of the indicated groups after infection. Nine 6-week-old BALB/c mice were infected with the parental or recoded viruses.
On days 2, 5, and 18 after infection, three animals of each group were euthanized (arrows), or when they lost more than 20% of their body weight. None of the
codon pair-deoptimized viruses (72-Min, 46-Med, and 27-Min) caused outward disease symptoms. Data show the mean ± SD.
(B and C) Quantification of virus replication in lungs of infectedmice. The right lung lobes were homogenized and viral titers determined by plaque assay in MDCK
cells (B) and by quantification of NP RNA molecules by qPCR (C). Data show the mean ± SD.
(D–F) Histopathological analysis of the mice lungs. The severity and distribution of alveolar necrosis (D), interstitial inflammation (E), and perivascular lympho-
plasmacytic inflammation (F) in lungs of infected animals were assessed and scored according the following scheme: 0, no lesions; 1, mild; 2, moderate; 3, severe
lesions. Data show the mean ± SD.
(G) Production of IFN-g by splenocytes. Mouse splenocytes were isolated 18-days post infection, stimulated with purified IAV virus or control protein for 3 days,
and production of IFN-g was measured by ELISA. Data show the mean ± SD.
(H) Immunohistochemical staining confirmed presence of IAV antigens in the necrotic bronchiolar epithelium of infected mice (red color). Scale bar, 20 mm.
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OPEN ACCESSshowed signs of regeneration with prominent pneumocyte type II
hyperplasia (Figure 4E; Figure S4) and moderate inflammation
(Figures 4D and 4F; Figure S4).
CPD Causes Unstable RNA and Inefficient Translation
While it is known that CPD causes attenuation of recoded viruses
because recoded genes produce less protein, it is unknown
which sequence features that arise through recoding are primar-
ily responsible for the reduction of protein production. Protein
production is primarily controlled by the quantity and translat-
ability of cytoplasmic mRNA. The amount of mRNA in the cyto-
plasm is mainly influenced by the RNA synthesis and degrada-6 Cell Reports 31, 107586, April 28, 2020tion rates (Paulsen et al., 2014). Yet, transcription and
translation of mRNA derived from genes manipulated by CPD
have received only cursory examination and, importantly,
mRNA stability has never been studied (Broadbent et al., 2016;
Coleman et al., 2008; Eschke et al., 2018; Futcher et al., 2015;
Le Noue¨n et al., 2014; Mueller et al., 2010; Shen et al., 2015;
Wang et al., 2015). We aimed to determine whether the primary
cause of attenuation by CPD lies at the level of mRNA produc-
tion, decay, or translation.
We first assessed RNA kinetics and protein production from
the parental and recoded NA genes in transiently transfected
HEK293T cells. To quantify expression, we constructed dual
Figure 4. Immune Protection of Vaccinated Mice
(A) The relative body weight of mice of the indicated groups after challenge with a parental 27-WT virus. Mice from the control group that lost more than 20% of
their body weight were euthanized. Two mice from the control group survived the challenge infection and started to gain weight on day 4 after challenge. Data
show as the mean ± SD.
(B) Anti-IAV neutralizing antibody titers in serum at days 18, 28 (day of challenge), and 38 after vaccination. Virus neutralization titers were determined in MDCK
cells and are expressed as the reciprocals of the highest serum dilution that showed complete inhibition of infection with 200 PFUs of 27-WT virus after 48 h.
72-Min, 46-Med, and 27-Min show similar high antibody titers. Mock control group shows high titers after 27-WT challenge.
(C–F) Histopathological analysis of the (mock-)immunized mice lung after challenge with the parental IAV virus. The severity and distribution of alveolar necrosis
(C), interstitial inflammation (D), pneumocyte type II hyperplasia (repair) (E), and perivascular inflammation (F) were assessed and scored on a scale from 0 (no
lesions) to 3 (severe lesions).
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OPEN ACCESSexpression plasmids, in which the expression of EGFP and NA
genes was driven by two different promoters. The plasmids
were transfected into HEK293T cells, and NA mRNA and protein
production was analyzed 24 h after transfection. NA mRNA
levels were significantly lower in cells transfected with plasmids
containing the codon pair-deoptimized genes 27-Min, 46-Med,
and 72-Min than in cells transfected with plasmid expressing
parental the 27-WT gene (Figure 5A). In contrast, NA mRNA
levels were only moderately decreased in the case of 72L-Max
(75% of the 27-WT) and increased in the case of 72H-Max
(170% of the 27-WT).
Protein amounts of the recoded NA genes were compared
to that of the 27-WT gene by western blotting (Figure 5B).
The codon pair-deoptimized NA genes 27-Min, 46-Med, and
72-Min produced less NA protein, while genes with increased
number of CpG dinucleotides produced comparable (72L-
Max) or increased (72H-Max) amounts of NA protein than
the 27-WT gene (Figure 5B). It is important to note that the
NA protein levels correlated very well with the levels produced
by the viruses in infected cells (Figure 2F), confirming that the
capacity of recoded genes to produce proteins is an inherent
characteristic of the sequence, and independent of virus
replication.
Next, we determined the RNA synthesis and RNA degradation
rates of the recoded NA genes. Both experiments were based onthe metabolic labeling of RNA with a ribonucleotide analog, bro-
mouridine (BrU) (Paulsen et al., 2014). The quantification of RNA
production did not show significant differences between the
different recoded NA genes (Figure 5C). In contrast, the rates
of RNA decay varied considerably among different NA RNA tran-
scripts as determined by pulse chase labeling (Figure 5D). The
RNA levels produced by the 27-WT or 72H-Max, 72L-Max genes
remained relatively stable up to 2 h after labeling; however, the
RNA produced by the codon pair-deoptimized genes 72-Min,
46-Med, and 27-Min was unstable and was rapidly degraded
(Figure 5D).
To confirm that the mRNA transcripts produced by the codon
pair-deoptimized genes were degraded faster than those of the
27-WT gene, we studied the stability of the different mRNA NA
transcripts within cells by analyzing their half-life following tran-
scription inhibition (Figure 5E). HEK293T cells were transfected
with the dual expression plasmids and the synthesis of new
mRNA in cells was inhibited with the RNA polymerase II inhibitor
flavopiridol after 24 h. The abundance of EGFP and NA tran-
scripts was quantified at different time points post inhibition by
qRT-PCR. The degradation rates of mRNA NA transcripts were
almost identical to those obtained in the BrU chase experiment
(Figure 5D), confirming that mRNA species made by codon
pair-deoptimized genes are less stable than those produced
by the parental 27-WT gene.Cell Reports 31, 107586, April 28, 2020 7
A B C
D E F
HG
Figure 5. RNA Kinetics and Protein Production by the Recoded NA Genes in Transiently Transfected HEK293T Cells
(A) Steady-state RNA levels produced by recoded NA genes in transiently transfected cells. Measurements of eight independent experiments are shown with
qPCR probe at the 30 end of the NA fragment (black) and two independent experiments with qPCR probe at the 50 end (red).
(B) Western blot analysis of NA protein production from recoded genes in transiently transfected cells from a plasmid background. EGFP protein levels were used
for normalization of the transfection efficiency.
(C) Transcription rates of recoded NA genes in HEK293T cells. NA RNA copy numbers were normalized to EGFP copy numbers to account for differences in
transfection efficiency. Data represent the means of four biological replicates ± SD.
(D and E) Stability of NA RNA transcripts in transfected cells determined by BrU pulse-chase labeling experiment (D) or transcription inhibitor flavopiridol (E). Data
are the means of three biological replicates ± SD.
(F) Translation efficiency of 29-nt footprints of recoded NA genes in transiently transfected cells from ribosome profiling experiments. Translation efficiency of all
cellular genes is given as a density plot with dotted line as SD for different experiments.
(G and H) Read density of sequencing (G) ribosome footprints and (H) total RNA from recoded part of 46-Med in transiently transfected cells. Red and black read
densities represent two replicates.
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OPEN ACCESSTranslation efficiency was determined by ribosome profiling
experiments (Figures 5F–5H; Figure S6). Numerous studies
have shown that 50 untranslated regions (UTRs) and N-terminal
protein-coding sequences can modulate translation efficiency
of genes in prokaryotes and eukaryotes because they determine
the structural stability of RNA at its 50 end, which in turn influ-
ences translation initiation rates (Goodman et al., 2013; Gu
et al., 2010; Tuller et al., 2010). However, because all recoded8 Cell Reports 31, 107586, April 28, 2020NA genes have identical 50 and 30 UTRs and N- and C-terminal
protein-coding sequences, we could exclude that potential dif-
ferences in NA protein production are due to cis-regulatory ele-
ments or the secondary structure of the 50-terminal region of NA
mRNA.
We observed a strong reduction of translation efficiency in the
codon pair-deoptimized constructs 72-Min, 46-Med, and 27-
Min (Figure 5F). The 72-Min gene had the lowest translation
Figure 6. RNA Kinetics of Recoded Viruses
(A) Relative NA to NP vRNA levels detected from
supernatants of infected MDCK cells. Quantitative
analysis of three independent experiments are
shown with qPCR probe at the 30 end of the NA and
NP fragment.
(B) Stability of NA mRNA transcripts in infected
MDCK cells determined by BrU pulse-chase labeling
experiment. Data are the means of three biological
replicates ± SD.
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tion of the corresponding mutant in vitro and in vivo. While 46-
Med and 27-Min also exhibited reduced translation efficiency,
we also identified an almost complete stop of translation after
760 nucleotides (Figure 5G; Figure S6). We confirmed presence
of full-length mRNA transcripts by qPCR with probes at the 30
and 50 ends (Figure 5A). The truncated protein could also be de-
tected by western blotting (Figure 5B). Mass spectrometric anal-
ysis showed that the truncated NA polypeptide contained only
the first 250 N-terminal amino acid residues. We did not identify
a similar premature cessation of translation in the third codon
pair-deoptimized construct, 72-Min. The translation efficiency
in this case was extremely low in this case and we obtained
only a few ribosome footprints, although the RNA levels were
comparable to other samples. In contrast, 72L-Max and 72H-
Max showed high translation efficiencies. This corresponded
well with the results showing that underrepresented codon pairs
are the cause of reduced translation efficiency and lead to
reduced protein production.
The analysis of RNA kinetics in transiently transfected cells
showed that the stability and translatability of RNA transcripts
produced by codon pair-deoptimized genes is reduced (Figures
5D–5F). To examine whether the same molecular mechanisms
might also be responsible for reduced protein production in the
virus context, we analyzed the stability of RNA produced by
the recoded viruses in infected cells. We first examined the ge-
netic composition of virus particles to rule out the possibility
that recoded viruses contain a skewed ratio of NA to NP vRNA
in their virions and found that the NA/NP vRNA ratio was unaf-
fected (Figure 6A). The analysis of RNA stability in infected
MDCK cells showed that NA RNA transcripts produced by
codon pair-optimized viruses decay faster than those of the
parental virus (Figure 6B). The stability of viral NA RNA was
slightly reduced in 46-Med, and markedly reduced in 72-Min
and 27-Min viruses (Figure 6B).
DISCUSSION
Several studies have shown that increasing the frequency of
CpG dinucleotides in the RNA virus genome reduces the virus
fitness (Atkinson et al., 2014; Burns et al., 2009; Tulloch et al.,
2014). Since CPD unintentionally increases the frequency of
CpG dinucleotides in recoded sequences, it was hypothesized
that the attenuation of mammalian codon pair-deoptimized vi-
ruses can be explained by the increased frequency of CpG dinu-cleotides in their genomes (Tulloch et al., 2014). In this study, we
have provided several lines of evidence that prove the oppo-
site—namely that underrepresented codon pairs rather than
CpG dinucleotides are primary determinants of CPD-based
attenuation. We achieved virus attenuation by CPD without
increasing the frequency of CpG dinucleotides in a recoded
sequence (27-Min), as evidenced by the fact that codon pair-
deoptimized viruses form smaller plaques on MDCK and A549
cells (Figures 2C–2E) and produce less NA protein than the
parental virus (Figure 2F). Similarly, we restored protein produc-
tion and reversed the attenuated phenotype of the 72-Min
mutant virus by replacing the non-optimal codon pairs with
optimal codon pairs, and thereby producing the 72L-Max and
72H-Max genes. Mutant viruses 72L-Max and 72H-Max show
no signs of attenuation in vitro (Figure 2) or in vivo (Figure 3),
although they still contain a large number of CpG dinucleotides.
Weobserved that theparental andallmutant viruses replicated
with similar kinetics and produced similar titers on MDCK cells
(Figure 2A), but three codon pair-deoptimized viruses—27-Min,
46-Med, and 72-Min—showed a strongly attenuated phenotype
on A549 cells (Figure 2B), growing to 100–1,000 times lower titer
than the parental virus. While the relatively unimpeded growth of
viruses that produceonly small amountsofNA inMDCKcellsmay
seem surprising, a similar observation has beenmade previously
in a study that analyzed replication of a codon pair-deoptimized
NA IAV mutant in MDCK and A549 cells (Yang et al., 2013). Our
results are consistent with observations suggesting that dissimi-
lar amounts of mucus are responsible for differences in the repli-
cationof IAVon the twocell lines.MDCKcells onlyproducea rela-
tively thin layer of mucus (Barnard et al., 2019; Harush-Frenkel
et al., 2008). In contrast, human alveolar carcinoma A549 cells
are secretory cells and produce substantial amounts of mucin
(Barnard et al., 2019; Berger et al., 1999). In addition, A549 cells,
like epithelial cells of the respiratory tract, harbor a layer ofmucus
that is rich in strongly sialylated glycoproteins. It appears that IAV
mutants do not need high NA levels to overcome the relatively
modest physical barriers to spread efficiently in MDCK cells.
Thus, single-step growth kinetics on MDCK cells have only
limited discriminatory power to reveal compromised fitness of
codon pair-deoptimized viruses.
In addition to CpG dinucleotides, CPD of vertebrate viruses
also increases the frequency of TpA/UpA dinucleotides in re-
coded sequences, albeit to a lesser degree (Kunec and Oster-
rieder, 2016). Indeed, all of our codon pair-deoptimized viruses
contain more UpA dinucleotides than the parental 27-WTCell Reports 31, 107586, April 28, 2020 9
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in genomes of analyzed viruses did not correlate with their repli-
cation or fitness levels either. For example, the 72L-Max mutant
contains a high number of UpA and CpG dinucleotides but did
not show any attenuation of replication (Figure 2; Table 1).
Thus, we conclude that neither UpA nor CpG dinucleotides
play a prominent role in the attenuation of recoded IAV mutants.
The results presented in this study refute the hypothesis, which
suggests that the effect of attenuation by CPD can be explained
by the number of CpG and UpA dinucleotides in codon pair-
deoptimized sequences. Two different studies evaluated the ef-
fect of CPD, and CpG/UpA dinucleotide frequencies on replica-
tion and pathogenicity of recoded influenza A virus mutants
(strain A/PR8/34 [H1N1]) (Gaunt et al., 2016; Yang et al., 2013).
Although these studies are not directly comparable, the level of
attenuation achieved by the elevation of CpG/UpA dinucleotide
frequencies (Gaunt et al., 2016) appears to be much weaker
than that by CPD (Yang et al., 2013). This observation is in line
with our results and indicates that the attenuation strategy based
on artificial elevation of CpG/UpA dinucleotide frequencies is
much less efficient than CPD. Several recent studies have also
shown that codon optimality is a major determinant of mRNA
stability (Boe¨l et al., 2016; Presnyak et al., 2015). Our results
demonstrate that codon pair choice is another major determi-
nant of RNA stability. Introduction of underrepresented codon
pairs into recoded NA genes did not have a measurable effect
on RNA transcription (Figure 5C), but it severely impaired the sta-
bility of mRNA transcripts and their translation efficiency (Figures
5D–5F).
In a similar study, IAV double mutants with codon pair deopti-
mized NA and hemagglutinin genes were completely attenuated
in BALB/c mice (Yang et al., 2013) and ferrets (Broadbent et al.,
2016). Similar to our results, the recoded NA RNA levels in in-
fected cells were significantly reduced. Our study explains this
observation as we show that transcripts produced by codon
pair-deoptimized genes decay much faster than parental tran-
scripts. We showed that the stability of RNA transcripts pro-
duced by codon pair-deoptimized genes is reduced in both
transfected (Figures 5D and 5E) and infected cells (Figure 6B).
While the increase of CpG (and UpA) dinucleotides in recoded
sequences might contribute to virus attenuation, our data
show that the increase of CpG dinucleotides in codon pair-deop-
timized sequences had negligible effects on protein production
and virus attenuation. Thus, it is plausible that CPD leads to virus
attenuation by different mechanisms. We argue that the principal
role in attenuation byCPD is exerted by underrepresented codon
pairs, which reduce the stability of recoded mRNA and inhibit
efficient translation.
We showed that neither CpG dinucleotides nor codon pairs of
the NNC-GNN type play an important role in the attenuation of
recoded viruses (72L-Max and 72H-Max). Since codon pairs of
the NNC-GNN type have extremely low CPS, CPD of vertebrate
virus genomes leads to an accumulation of these codon pairs in
recoded sequences. We speculated that codon pairs of the
NNC-GNN type have low CPS, but they do not correlate propor-
tionally with their role in attenuation by CPD. For example, the
low average CPS of 72L-Max is solely due to NNC-GNN codon
pairs (Figures 1B and 1C), but the virus mutant 72L-Max is not10 Cell Reports 31, 107586, April 28, 2020attenuated. It is possible that amodification of the current recod-
ing approach, which would not lead to the accumulation of un-
derrepresented codon pairs of the NNC-GNN type, could lead
to even stronger attenuation of recoded viruses.
As a final implication, our work suggests that inhibitory effects
of individual non-optimal codon pairs are unequal. The identifica-
tion of a clear premature translation termination point in different
recoded genes (Figure 5G; Figure S6) suggests that reduction of
protein production is not the sum of small negative effects ex-
erted by individual underrepresented, non-optimal codon pairs
(Coleman et al., 2008). Instead, some codon pairs might have
strong inhibitory effects on translation and associated mRNA
decay. This emphasizes the need for future research aimed at
determining the contribution of individual codon pairs to mRNA
destabilization and translation inhibition. Such knowledge could
ultimately lead to the development of safer, non-reverting atten-
uated live attenuated virus vaccines for animal and human use.STAR+METHODS
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anti-Influenza A H1N1 BIO RAD Cat#5315-0064; RRID:AB_620739
anti-beta-actin Cell Signaling Cat#4970; RRID:AB_2223172
anti-Influenza A/WSN/1933 (H1N1) This paper N/A
Bacterial and Virus Strains
A/WSN/1933 (H1N1), 8 plasmid system Hoffmann et al., 2000 PMID: 10801978
Chemicals, Peptides, and Recombinant Proteins
Flavopiridol MedChem Express Cat#HY-10005
5-Bromouridine (BrU) Sigma-Aldrich Cat#850187
Uridine Sigma-Aldrich Cat#U3750
Protein G Dynabeads Thermo Fisher Cat#10004D
Critical Commercial Assays
RNeasy Plus Mini Kit QIAGEN Cat#74136
RTP DNA/RNA Virus Mini Kit Stratec Cat#1040100300
TruSeq Stranded mRNA Kit Illumina Cat#20020595
Deposited Data
Neuraminidase gene sequences This paper GenBank: MN176602, MN176603, MN176604,
MN176605, MN176606, MN176607
Raw and analyzed ribosome profiling data This paper GEO: GSE134752
Experimental Models: Cell Lines
HEK293T cell ATCC CRL-3216
MDCK II cells ATCC CCL- 2936
A549 cells ATCC CCL-185
Experimental Models: Organisms/Strains
BALB/cJRj Janvier SC-BALBJ-F
Oligonucleotides
Primers and probes for RT-qPCR, see Table S1 This paper N/A
Recombinant DNA
Recoded neuraminidase genes BioBasic N/A
pVITRO2-MCS InvivoGen N/A
A/WSN/1933 (H1N1) plasmids Hoffmann et al., 2000 PMID: 10801978
Software and Algorithms
GraphPad Prism 8.1.2 GraphPad Software https://www.graphpad.com/
R, version 3.5.3 R Foundation for Statistical
Computing
https://www.r-project.org/
RiboDiff Zhong et al., 2017 https://github.com/ratschlab/ribodiff
ImageJ Schneider et al., 2012 https://imagej.nih.gov/ij/
Flexbar Dodt et al., 2012 https://github.com/seqan/flexbar
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tophat2 Kim et al., 2013 http://ccb.jhu.edu/software/tophat/index.shtml
quasR Gaidatzis et al., 2015 https://github.com/fmicompbio/QuasR
bowtie2 Langmead and Salzberg, 2012 http://bowtie-bio.sourceforge.net/bowtie2/
index.shtml
Article
ll
OPEN ACCESSRESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dusan
Kunec (dusan.kunec@fu-berlin.de).
Materials Availability
Plasmids generated in this study are available upon request.
Data and Code Availability
Unprocessed datasets generated in this study are available through Mendeley Data: https://doi.org/10.17632/rsxsyy5wrd.1. Se-
quences of the recoded IAV NA genes have been deposited in GenBank: MN176602, MN176603, MN176604, MN176605,
MN176606, MN176607. Raw and analyzed ribosome profiling data have been deposited in the NCBI’s Gene Expression Omnibus
database (GEO: GSE134752).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
Madin-Darby canine kidney (MDCK.2, ATCC CCL- 2936), human adenocarcinomic alveolar basal epithelial A549 (ATCC CCL-185)
and human embryonic kidney HEK293T (ATCC CRL-3216) cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml) at 37C and 5% CO2.
Mouse lines
Female 6 -week-old BALB/c mice (BALB/cJRj) were purchased from Janvier and distributed randomly. All the mice were maintained
in a pathogen-free animal facility under standard 12 h light/12 h dark cycle at 21Cwith access to normal chow and water ad libitum.
Animal experiments
Animal experiments were conducted in accordance with the EU legislation for the use of animals for scientific purposes (Directive
2010/63/EU) and German law (paragraph 8 Tierschutzgesetz). Animal experiments were approved by the Landesamt f€ur Gesundheit
und Soziales in Berlin, Germany (approval G0291/17). Female 6-week-old BALB/c mice were purchased from Janvier, distributed
randomly to 7 groups of 9 animals, and infected intranasally with 5 3 104 PFU of IAV in 30 ml DMEM medium under ketamine and
xylazine anesthesia (Plumb, 2015). Mice were infected with 27-WT, 72-Min, 46-Med, 72H-Max, 72L-Max, 27-Min virus, or mock-in-
fected with DMEM medium. The body weight was measured every day over the whole duration of the experiment. Mice which
showed signs of severe disease (ruffled fur, tremors, respiratory distress, and lack of activity), or lost more than 20% of their body
weight were euthanized. On day 2, 5 and 18, three mice from each group were killed and blood, lungs and spleens were collected
and analyzed for viral titers and histology (see below). In a second experiment, mice were vaccinated intranasally with 30 mL inoculum
containing 5 3 104 PFU of attenuated mutant viruses 72-Min, 46-Med, 27-Min, or mock-vaccinated with DMEM. On day 28 post
vaccination mice were challenged with 5 3 105 PFU of parental 27-WT virus. Blood was taken on day 18, 28 and 38 after initial
infection.
METHOD DETAILS
Virus design
The viral mutants were based on the prototype IAV strain A/WSN/1933 (H1N1) (Hoffmann et al., 2000). Viral mutants differed from
each other in how the neuraminidase (NA) gene was encoded. To ensure unaltered packaging and replication of the recoded NA seg-
ments, only the central part of the NAORF (1,017 nt, 339 codons) was recoded, leaving the first 183 nt (61 codons) and the last 162 nt
(54 codons) of the ORF unmodified. The NA gene was recoded using custom perl scripts, utilizing codon pair bias observed in human
protein coding sequences (Kunec and Osterrieder, 2016). Recoding preserved the amino acid sequence but modified the number of
CpG dinucleotides and/or codon pair bias of the recoded genes. The recoded NA segments were synthesized (BioBasic, Inc) ande2 Cell Reports 31, 107586, April 28, 2020
Article
ll
OPEN ACCESScloned into a pHW vector of the standard 8-plasmid A/WSN/1933 reverse genetics system (Hoffmann et al., 2000). Gene sequences
can be retrieved from the NCBI sequence database Genbank: MN176602, MN176603, MN176604, MN176605, MN176606,
MN176607.
Cell culture and virus recovery
Mutant viruses were recovered after transfection of the A/WSN/1933 plasmids into susceptible HEK293T cells (Hoffmann et al.,
2000). Infectious medium was harvested and virus was propagated in MDCK.2 cells grown in infection medium (DMEM supple-
mented with 0.2% BSA, 0.1% FBS, 2 mM Na-pyruvat, 2 mg/mL TPCK-treated trypsin). Cell culture medium was harvested 2-
3 days after inoculation, when at least 75% of the cell monolayer exhibited CPE. Virus titers of the cell supernatant were determined
by titration on MDCK.2 cells. To confirm sequences of recoded NA genes, viral RNA was isolated using RTP DNA/RNA Virus Mini Kit
(Stratec SE), reverse transcribed with M-MLV reverse transcriptase (Promega) and sequenced by Sanger sequencing.
Virus titration and plaque size measurement
To determine virus titers and virus-induced plaque sizes,MDCK.2 or A549 cells were grown in 6-well plates and infectedwith 500 ml of
serial 10-fold dilutions of the virus. After a 1 h adsorption period, the medium was removed and cells were overlaid with Eagle’s min-
imum essential medium (EMEM) containing 0.6% microcrystalline cellulose Avicel (FMC BioPolymer), 0.1% FBS, 2 mg/ml TPCK-
Trypsin, 0.2% BSA, 0.05% NaHCO3, 0.01% diethylaminoethyl-dextran, penicillin (100 U/ml) and streptomycin (100 mg/ml). After 2
to 3 days, cells were washed with 1 3 PBS, fixed with 2% paraformaldehyde. MDKC.2 cells were stained with 0.1% crystal violet
(in 25%methanol) for 30min. Immunohistochemistry was performed for A549 cells. Cells were fixedwith 2%paraformaldehyde, per-
meabilizedwith 0.1%Triton X-100, and blockedwith 3%bovine serum albumin (BSA) in PBS. Cells were then incubatedwith anti-IAV
mouse serum obtained frommice used in this study (dilution 1:1000) for 1 h, and then with goat anti-mouse IgG-Alexa Fluor 568 sec-
ondary antibody (dilution 1:2000, Invitrogen) for 45min to visualize plaques. Images of an entire well of a 6-well plate were takenwith a
plate imager (Bioreader-6000 FZb, BIO-SYS), and images of individual plaques were taken at 50- and 100-fold magnification using
an inverted fluorescence microscope (Axiovert S100, Zeiss). The plaque diameters of 100 randomly selected plaques of each virus
were determined with ImageJ software (Schneider et al., 2012).
Multi-step growth kinetics
To assess virus growth kinetics, confluent MDCK.2 or A549 cells grown in 12-well plates were infected with 500 ml of recombinant
virus at a multiplicity of infection (MOI) of 0.0001. After a 1 h adsorption period, the medium was changed to infection medium (con-
taining 1 mg/mL TPCK-treated trypsin for A549 cells or 2 mg/mL for MDCK.2 cells). At the indicated times after infection, cell culture
medium was taken and viral titers were determined by plaque assays.
Western blotting
Protein production bymutant viruseswas assessed inMDCK.2 cells. Confluent cells grown in 6-well plates were infected at anMOI of
5. After 1 h, medium was changed to infection medium and cells were collected and analyzed after an additional 4 h. To assess NA
production by transfection experiments, 70% confluent HEK293T cells were transfected with pVITRO2-EGFP-NA expression plas-
mids that contained the various recoded genes and collected 24 h post transfection. Cells were lysed in radioimmunoprecipitation
assay (RIPA) buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1% Nonidet P-40; 0.5% sodium deoxycholate, 0.1% SDS) containing pro-
tease inhibitors (Roche) and benzonase (Novagen). Proteins in cell lysates were separated by sodium dodecyl sulfate (SDS) poly-
acrylamide gel electrophoresis (PAGE) under reducing conditions, and proteins were transferred to PVDF membranes using a
semi-dry blotting system (Towbin et al., 1979). The membranes were blocked for 1 h at room temperature in 3% milk in PBS, with
0.05%Tween-20.Membranes were incubated with primary antibodies for 16 h at 4C. To detect NA, NP, NS-1, EGFP and beta-actin,
monoclonal anti-NA (GT288, GeneTex), anti-NP (GT778, GeneTex), or polyclonal anti-NS1 (Schierhorn et al., 2017), anti-EGFP (Cell
Signaling), or anti-beta-actin (Cell Signaling Technology) antibodies, respectively, were used. As secondary antibodies, a horseradish
peroxidase-conjugated anti-mouse IgG (1:2000, Sigma) or anti-rabbit IgG antibody (1:2000, Cell Signaling Technology) was used.
Antibody binding was visualized by chemiluminescent ECL prime western blotting detection reagent (GE Healthcare).
Mass spectrometry
The identity of truncatedNAprotein was determined bymass spectrometry. After separation by SDS-PAGE, gel bands containing the
truncated NA protein were cut out, proteins in the gel slices were reduced with dithiothreitol, ankylated with chloroacetamide, and
digested in situ with trypsin, chymotrypsin, elastase or AspN (Morrison et al., 2015). The digested peptides were extracted from the
gel matrix and analyzed by nano-liquid chromatography tandem mass spectrometry on a LTQ Orbitrap Elite mass spectrometer
(Thermo Fischer Scientific) (Morrison et al., 2015). Amino acid sequence of NA peptides was determined by searching the UniProt
virus database with Mascot search engine.
Transient transfections
To quantify NA expression, the NA and EGFP genes were cloned into a bicistronic reporter plasmid pVITRO2 (InvivoGen), which al-
lows constitutive co-expression of two genes of interest (Eschke et al., 2018). The obtained plasmids pVITRO2-EGFP-NA wereCell Reports 31, 107586, April 28, 2020 e3
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duction was analyzed 24 h after transfection.
RNA extraction and quantitative RT-PCR
Total RNA from cells was isolated using the RNeasy Plus Mini kit (QIAGEN) and converted into cDNA with M-MLV reverse transcrip-
tase (Promega) and random primers according to the manufacturer’s instructions. cDNA was quantified on the StepOnePlus Real-
Time PCR System (Thermo Fisher Scientific) using Hot FIREPol Polymerase (Solis Biodyne). Primers and TaqMan probes are listed in
Table S1. Gene-specific primer and probe sets for NA, NP and EGFP were designed using Primer Express 3.0.1 software (Thermo
Fisher Scientific). Expression of different NA gene variants was quantified using a single primer and probe set because they were
designed to amplify non-recoded 30 or 50 end of the NA gene. The copy numbers were determined from the calibration curves gener-
ated based on known concentrations of pVITRO2-EGFP-NA, or pHW WSN/33 IAV plasmids.
Relative number of NA and NP copies in virions
MDCK cell were infected with a MOI of 0.001. After 48 h supernatant was collected and viral RNA was isolated using RTP DNA/RNA
Virus Mini Kit (Stratec SE), reverse transcribed with M-MLV reverse transcriptase (Promega) and RT-qPCR from NA and NP frag-
ments was performed as described above.
RNA stability assay based on transcription inhibition
Stability of transcripts was measured indirectly by analyzing the half-life of RNA transcripts following transcription inhibition with fla-
vopiridol (Hycultec). HEK293T cells were transfectedwith pVITRO2-EGFP-NA plasmids. Flavopiridol was added to cultured cells 24 h
after transfection at a final concentration of 1 mM. Cells were then cultured for additional 0, 1, 2, or 5 h, and RNA was isolated and
quantified as described above.
RNA synthesis and degradation assays based on RNA labeling with 5-bromouridine
The rate of RNA synthesis and degradation was determined in HEK293T cells by metabolic labeling of nascent RNA with a ribonu-
cleotide analog, bromouridine (BrU, Sigma-Aldrich) (Paulsen et al., 2014). Cells grown in 6-well plates were transfected with expres-
sion plasmids pVITRO2-EGFP-NA (1 mg/well) and the BrU pulse (-chase) experiments were done 24 h after transfection.
To determine the rate of RNA synthesis, nascent RNA was pulse-labeled with BrU 800 ml of 2 mM BrU (Sigma-Aldrich, #850187) in
DMEM containing 10% FBS was added to infected 100% confluent MDCK cells or transfected 80% confluent 293Ts. After 2 h for
infection and 1 h for transfection expresiments, excess of BrU was removed. For 0h time point RLT buffer (QIAGEN) was directly
added, all other cells were washed 3 times with 20 mM PBS. 1.2 mL Uridine (Sigma-Aldrich, #U3750) in DMEM containing 10%
FBS was added for indicated time points (0.5 h to 3 h) and incubated under normal growth conditions. At indicated time points cells
were washed with PBS, RLT buffer (QIAGEN) was added and cells were harvested. RNAwas isolated with RNeasy Plus kit (QIAGEN).
For the preparation of the purification beads, 15 mL of anti-mouse IgG magnetic Dynabeads (Thermo Fisher Scientific, #10004D)
per sample are transferred to a 1.5 mL microfuge Protein Low binding tube. Beads are captured with magnetic stand and storage
buffer was removed. For 6 samples beads were resuspend in 600 mL BrU-IP buffer (0.05% Tween in RNase free PBS), captured
on the magnetic stand and supernatant was aspirated. After one wash with BrU-IP buffer, beads are resuspended in 300ml (6 sam-
ples) BrU-IP buffer supplemented with 1 ml RNase inhibitor (RNasin, Promega). For each sample 1 ml (0.5 mg) BrdU antibody (Becton
Dickinson PharMingen, #00000000555627000000000000000000000000) was added. Samples are incubated for 30 min at room
temperature with gentle rotation. After three washes of beads as described above, beads are resuspend in 100 ml BrU-IP buffer
per sample supplemented with RNase inhibitor.
For isolation of BrU labeled RNA, 100 ml of the magnetic beads conjugated with the BrdU antibody are added to the isolated RNA
and 135 ml 1 3 BrU-IP buffer was added. Samples are incubated for 60 min at room temperature with gentle rotation in Protein low
binding tubes. Beads are washed twice with BrU-IP buffer for 5 min on the rotator. Afterward beads are captured on the magnetic
stand and supernatant was aspirated. Three additional washes with BrU-IP buffer were performed and the bead pellet was resus-
pended in 40 ml DEPC-water and incubate for 10 min in a 95C heat block to elute BrU-RNA from the beads. Beads are captured
on themagnetic stand and supernatant was collected into a clean 1.5mLmicrofuge tube. Afterward NA, NP or GFP copies of isolated
BrU RNA was reverse transcribed with oligo dT and quantified by RT-qPCR as described above.
For the comparison of the RNA synthesis rates transfected HEK293T cells are labeled for 30 min with BrU and labeled RNA is
measured by qPCR following the procedure described above.
Ribosome profiling
HEK293T cells were transfected with expression plasmids pVITRO2-EGFP-NA for 24 h. Ribosome profiling was performed as
described in Calviello et al. (2016), except that the mRNA fragments were excised between 18-nt and 35-nt marker oligos, instead
of 27-nt and 30-nt. Unfragmented RNA extracted from cell lysates was converted into sequencing libraries using the Illumina TruSeq
Stranded mRNA kit. Samples were pooled and sequenced on a HiSeq 4000 (Illumina) device to generate 51-nt single-end reads.
Read sequences and analyses have been deposited into the Gene Expression Omnibus (GEO) database and are accessible through
GEO Series accession number GSE134752. Sequencing reads were demultiplexed and adaptor-trimmed using FLEXBAR (Dodte4 Cell Reports 31, 107586, April 28, 2020
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using bowtie2 (Langmead and Salzberg, 2012). Only reads with mapping quality 24 or higher were kept, which also filtered out reads
mapping to the constant regions at the beginning and end of the NA constructs. Sequencing reads per gene as annotated in the Re-
fSeq database were counted using quasR (Gaidatzis et al., 2015). Translation efficiencies from readcounts were calculated using
RiboDiff (Zhong et al., 2017).
Viral load and copy number in the lungs
The right lung lobeswere homogenized in 1mLDMEMand virus titer was determined by plaque assay as described earlier. Total RNA
was isolated from 200 ml of the homogenized lung and the RNA copy numbers of IAV NA and NP fragments were determined by RT-
qPCR as described above.
Antibody titers
Anti-IAV antibody titers were assessed by hemagglutination inhibition (HAI), and virus neutralization assays in blood serum collected
on day 18 post infection from first animal experiment exactly as described in the World Health Organization manual on animal influ-
enza diagnosis and surveillance (WHO, 2002). In the vaccination experiment blood serumwas taken on day 18, 28 and 38 and anti IAV
antibody titers were determined with virus neutralization assay (WHO, 2002).
Cytokine detection by ELISA
Spleens were removed frommice, homogenized and filtered through 70 mmcell strainers (Becton Dickinson) to obtain single cell sus-
pensions. Erythrocytes in spleen cell suspension were lysed using ACK buffer containing 150mMNH4Cl, 0.1mMKHCO3 and 0.1mM
Na2EDTA, pH 7.2 for 3 min. Cells were washed and re-suspended in complete RPMI 1640 medium (cRPMI) and counted using a
CASY automated cell counter (Roche). A total of 1 3 106 splenocytes were stimulated with 10 mg/ml purified 27-WT virus or
10 mg/ml control protein purified from cell supernatant for 3 days. Cells were cultured in cRPMI containing 10% FCS, and Penicillin
[100 U/ml]/ Streptomycin [100 mg/ml]. Supernatants were analyzed for IFN-g using Ready-Set-Go Elisa Kits (eBioscience) according
to the manufacturer’s instructions.
For purification of virus antigen, 27-WT was grown in MDCK.2 cells for 48 h. Supernatants were collected and cleared from cell
debris by centrifugation for 10 min at 5,000 3 g. Virus was purified using a 20% sucrose cushion in TNE buffer (10 mM Tris,
1 mMEDTA, 100mMNaCl) by centrifugation for 2 h at 100,0003 g. The resulting virus pellet was dissolved in TNE buffer and protein
concentration was determined with BCA assay. As a control protein supernatant of uninfected MDCK.2 cells was used.
Histopathology and immunohistochemistry
The left lung of mice was carefully removed, fixed in formalin pH 7.0 for 48 h, embedded in paraffin, and cut into 2 mm sections. Lung
sections stained with hematoxylin and eosin were evaluated by microscopy in a blinded fashion (Dietert et al., 2017). Histological
examination revealed amoderate to severe, multifocal to coalescing, acute necrotizing bronchointerstitial pneumonia. The patholog-
ical features assessed were damage to the airway epithelium (necrosis of bronchi, bronchioli and alveoli) and inflammation (perivas-
cular, interstitial, bronchus associated lymphoid tissue (BALT)) as well as pneumocyte type II hyperplasia (repair). Each feature was
scored: 0 (no lesion), 1 (mild), 2 (moderate), 3 (severe). Viral antigens in lung sections were visualized by immunohistochemical stain-
ing (Dietert et al., 2017). Briefly, slides were deparaffinized and IAV antigens were retrieved by boiling in citrate buffer for 12 min in a
microwave oven. Slides were first incubated with goat polyclonal anti-IAV H1N1 antibody (dilution 1:250; Bio-Rad Laboratories;
5315-0064) for 1 h, and then with alkaline phosphatase-conjugated rabbit anti-goat antibody (1:200, Vector Laboratories) for
30 min at RT. The alkaline chromogen triamino-tritolyl-methanechloride (neufuchsin) served as phosphatase substrate for color
development. Sections were counterstained with hematoxylin, dehydrated through alcohol washes of increasing concentrations,
cleared in xylene andmounted on coverslips. Incubation with a purified goat antibody at the same dilution instead of primary antibody
served as a negative control.
QUANTIFICATION AND STATISTICAL ANALYSIS
Histopathology of mouse lungs
Lung sections were evaluated by microscopy in a blinded fashion. The pathological features assessed were scored: 0 (no lesion), 1
(mild), 2 (moderate), 3 (severe).
Statistical analysis
Statistical tests were performed using GraphPad/ Prism. Statistical details of experiments can be found in the figure legends. Exact
values of n and statistical tests are indicated in figure legends. P values are indicated in Figures. Data are presented as mean ± SD.
P values of plaque diameters were calculated using one-way ANOVA Bonferroni’s multiple comparison test (*** P <0.001).Cell Reports 31, 107586, April 28, 2020 e5
